QUALCOMM Incorporated Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

Significant Accounting Policies (Tables)

Significant Accounting Policies (Tables)

12 Months Ended

Sep. 30, 2018

The carrying values of our non-marketable equity investments are recorded in other noncurrent assets and were as follows (in millions):



	September 30, 2018		September 24, 2017
Equity method investments	$	402	$	379
Cost method investments	650		603
	$	1,052	$	982

Equity Method Investments

The carrying values of our non-marketable equity investments are recorded in other noncurrent assets and were as follows (in millions):



	September 30, 2018		September 24, 2017
Equity method investments	$	402	$	379
Cost method investments	650		603
	$	1,052	$	982

Notional Amounts of Outstanding Derivative Positions

Gross Notional Amounts: The gross notional amounts of our interest rate and foreign currency derivatives by instrument type were as follows (in millions):



	September 30, 2018		September 24, 2017
Forwards	$	682	$	163
Options	1,375		2,333
Swaps	1,750		3,000
	$	3,807	$	5,496

The gross notional amounts by currency were as follows (in millions):



	September 30, 2018		September 24, 2017
Chinese renminbi	$	650	$	1,460
Euro	938		146
Indian rupee	336		772
Japanese yen	17		68
Korean won	—		50
United States dollar	1,866		3,000
	$	3,807	$	5,496

Share-based compensation expense, related to all share-based awards

Total share-based compensation expense, related to all of our share-based awards, was comprised as follows (in millions):



	2018			2017			2016
Cost of revenues	$	38		$	38		$	40
Research and development	594			588			614
Selling, general and administrative	251			288			289
Share-based compensation expense before income taxes	883			914			943
Related income tax benefit	(140		)	(161		)	(190		)
	$	743		$	753		$	753

Schedule of diluted earnings per share

The following table provides information about the diluted earnings per share calculation (in millions):



	2018	2017	2016
Dilutive common share equivalents included in diluted shares	—	13.0	13.9
Shares of common stock equivalents not included because the effect would be anti-dilutive or certain performance conditions were not satisfied at the end of the period	51.2	3.0	2.4